SCHEMBL682431

SCHEMBL682431

O=C(OCO)OCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13949507 0.89 ALDH1A1 (0.40)
SCHEMBL7530559 0.89 ALDH1A1 (0.40)
SCHEMBL7332820 0.84
SCHEMBL6009174 0.80
SCHEMBL14996151 0.79
SCHEMBL9040811 0.79
SCHEMBL11986242 0.78 ALDH1A1 (0.38)
SCHEMBL8275261 0.78 TSHR (0.46)
SCHEMBL11986240 0.78 ALDH1A1 (0.38)
SCHEMBL6006785 0.76 ALDH1A1 (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240165143-A1 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO EMORY UNIVERSITY 2024-05-23 US claimed
CN-117106294-A Medical packaging bottle plastic material and preparation method thereof 沧州维康食品药品包装有限公司 2023-11-24 CN claimed
EP-4040965-A2 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO Emory University (US) 2022-08-17 EP claimed
EP-4017501-A1 N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO Emory University (US) 2022-06-29 EP claimed
WO-2021159044-A1 N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO EMORY UNIVERSITY (US) 2021-08-12 WO claimed
WO-2021137913-A2 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO EMORY UNIVERSITY (US) 2021-07-08 WO claimed
EP-4286329-B1 LITHIUM-DOPED SILICON-BASED NEGATIVE ELECTRODE ACTIVE MATERIAL, METHOD OF PRODUCING THE SAME, METHOD OF POST-TREATING THE SAME, AND NEGATIVE ELECTRODE AND SECONDARY BATTERY INCLUDING THE SAME SK ON CO LTD (KR) 2025-05-14 EP disclosed
US-20230395800-A1 LITHIUM-DOPED SILICON-BASED NEGATIVE ELECTRODE ACTIVE MATERIAL, METHOD OF PRODUCING THE SAME, METHOD OF POST-TREATING THE SAME, AND NEGATIVE ELECTRODE AND SECONDARY BATTERY INCLUDING THE SAME SK ON CO., LTD. (KR) 2023-12-07 US disclosed
EP-4286329-A1 LITHIUM-DOPED SILICON-BASED NEGATIVE ELECTRODE ACTIVE MATERIAL, METHOD OF PRODUCING THE SAME, METHOD OF POST-TREATING THE SAME, AND NEGATIVE ELECTRODE AND SECONDARY BATTERY INCLUDING THE SAME SK On Co., Ltd. (KR) 2023-12-06 EP disclosed
CN-117106294-A Medical packaging bottle plastic material and preparation method thereof 沧州维康食品药品包装有限公司 2023-11-24 CN disclosed
US-20230257611-A1 INK JET INK AND INK JET RECORDING METHOD FUJIFILM CORPORATION (JP) 2023-08-17 US disclosed
WO-2023141636-A1 PRODRUGS OF 2-BROMO-LSD (2-BROMOLYSERGIC ACID DIETHYLAMIDE) TERRAN BIOSCIENCES INC. (US) 2023-07-27 WO disclosed
US-20230220227-A1 INK JET RECORDING METHOD FUJIFILM CORPORATION (JP) 2023-07-13 US disclosed
EP-0082666-A1 Bis-hydroxymethyl carbonate bridged antibacterial agents PFIZER INC. (US) 1983-06-29 EP disclosed
EP-0082666-A1 Bis-hydroxymethyl carbonate bridged antibacterial agents PFIZER INC. (US) 1983-06-29 EP disclosed
EP-0082666-A1 Bis-hydroxymethyl carbonate bridged antibacterial agents PFIZER INC. (US) 1983-06-29 EP disclosed
US-4359472-A DERIVED FROM A PENICILLIN AND A BETA-LACTAMASE INHIBITOR PFIZER INC. (US) 1982-11-16 US disclosed
US-4359472-A DERIVED FROM A PENICILLIN AND A BETA-LACTAMASE INHIBITOR PFIZER INC. (US) 1982-11-16 US disclosed
US-4359472-A DERIVED FROM A PENICILLIN AND A BETA-LACTAMASE INHIBITOR PFIZER INC. (US) 1982-11-16 US disclosed
US-3950833-A Roll covering composition BELOIT CORPORATION (US) 1976-04-20 US disclosed